Skip to main content

Table 4 30-day postoperative adverse events in patients undergoing hip hemiarthroplasty stratified by occurrence of surgical site infection

From: Incidence and risk factors for surgical site infection (SSI) after primary hip hemiarthroplasty: an analysis of the ACS-NSQIP hip fracture procedure targeted database

 

No SSI

SSI

P-value

Total (n)

5989

80

 

Mortality (%)

6.48

6.25

0.9342

Systemic (%)

 Sepsis

1.27

22.50

< 0.0001*

Cardiovascular (%)

 Myocardial infarction

2.57

2.50

0.9680

Pulmonary (%)

 Unplanned intubation

1.24

0

0.3171

 Pneumonia

4.12

6.25

0.3438

Renal (%)

 Acute renal failure

0.33

1.25

0.1657

 Progressive renal insufficiency

0.37

0

0.5871

Hospital-acquired conditions (%)

 Wound dehiscence

0.08

2.50

< 0.0001*

 Urinary tract infection

4.41

5.00

0.7980

 Deep venous thrombosis

0.85

1.25

0.7009

 Pulmonary embolism

0.82

1.25

0.6712

Other (%)

 Transfusion, perioperative

15.61

18.75

0.4429

 Readmission

8.40

52.50

< 0.0001*

 Reoperation

2.10

48.75

< 0.0001*

Failed wean (%)

0.63

1.25

0.4937

  1. Abbreviation: SSI Surgical site infection
  2. *Statistically significant (P < 0.05)